Actively Recruiting
Randomized Trial Comparing Liposomal Bupivacaine EXPAREL4 and Xylocaine4 for Pain Control After Rib Cartilage Removal in Nasal Surgery
Led by Mayo Clinic · Updated on 2026-09-11
60
Participants Needed
1
Research Sites
53 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate whether injecting EXPAREL4, a long-acting numbing medication approved by the U.S. Food and Drug Administration, can reduce pain after rib cartilage removal compared to the standard injection of XYLOCAINE4. The trial focuses on patients undergoing nasal surgery requiring costal cartilage harvest, seeking to improve post-surgical pain control. Participants are randomly assigned to one of two groups one group receives a subcutaneous injection of 106 mg 8 mL of EXPAREL4 at the site of cartilage removal, while the other group receives the standard treatment of 8 mL of 1% lidocaine with epinephrine XYLOCAINE4. Both injections are administered on the day of the nasal surgery. The study is conducted as a Phase IV randomized, single-blind trial with parallel design. During the study, participants pain levels and use of oral pain medications are monitored for 7 to 10 days following the last administration of the study treatment. Researchers also observe any adverse reactions within this period. The study involves standard clinical visits and assessments related to pain measurement and safety monitoring. The trial is sponsored by Mayo Clinic and plans to complete by September 2027.
CONDITIONS
Brief Title
Pain Control for Undergoing Costal Cartilage Harvesting
Research Team
A
Amy Tuchscherer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here